Is Eyebright Medical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Eyebright Medical pays dividends. Last time was Wednesday 5th of June 2024 where the investors holding the stock on Wednesday 5th of June 2024 were paid CNY0.49 per share. Over the last 4 times between 2021 and 2024, Eyebright Medical has paid CNY1.65 with an average of CNY0.41 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Eyebright Medical 10 years ago, but if you had invested on Wednesday 29th of July 2020 when the price was CNY133.61, you would have made a loss of CNY-55.58 per share or -41.60%
Yes, the average daily trading liquidity for Eyebright Medical is CNY1.57 million. You should therefore be able to get in and out of your positions relatively fast.
Eyebright Medical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.62, the company's ability to pay off the debt is good. Eyebright Medical has a very good net profit margin of 30.80% and should have very high tolerances against inflation.
We have calculated the inflation risk for Eyebright Medical to be low [0.15 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.